User:Padraig Doolan/sandbox
Archport Ltd. was a bioprocessing start-up company created in 1998 to provide contract production and development services for the biopharmaceutical industry.[1] In 2006, it was acquired by CU Chemie Uetikon and was relaunched as BioUETIKON in 2008.[2]
Background
[edit]In 1998, the National Cell & Tissue Culture Centre (NCTCC), Dublin City University (DCU) launched a spin-off bioprocessing start-up company, Archport Ltd. to provide contract production and development services for the biopharmaceutical industry.[3] The company generated 25-30 jobs on campus over a 15-year period and maintained some research activity on campus, employing scientists and supporting PhD students consistently over the following 28 years.[4]
Services
[edit]Archport's range of services included GMP compliant animal cell culture and purification of active biopharmaceutical ingredients for clinical trials or market ready drugs, such as recombinant proteins, cell therapy products and monoclonal antibodies.[5][6] It also provided the scale-up of mammal or insect cell cultures, purification processes and joint R&D services.[7][8]
BioUETIKON
[edit]In September 2006, DCU announced that Archport Ltd., has been acquired by CU Chemie Uetikon, a division of the Swiss-based CPH Chemie and Papier Holdings Group, with a major investment programme planned to create up to 30 high tech jobs.[9][10][11][12] CU Chemie Uetikon took an 80 per cent share of Archport, while DCU retained a 20 per cent holding.[13][14][15][16] CU Chemie Uetikon’s objective was to build on its already-established purpose-built biopharmaceutical laboratories on the DCU campus by providing significant investment in new plant and staff for an expansion programme.[17][18][19][20]
The new service-oriented bioprocessing company, now named BioUETIKON, was formally launched in April 2008.[21] The company offers GMP-compliant mammalian cell cultures and downstream processing for development or manufacture of active pharmaceutical ingredients (APIs).[22] Archport Ltd. (and its partner Institute the National Institute for Cellular Biotechnology) was visited by (later US Secretary of State and 2016 Presidential Candidate) Senator Hillary Clinton on Thursday, March 28, 2002[23]
References
[edit]References
[edit]- ^ "Spotlight on NICB". DCU Website. Retrieved May 20, 2016.
- ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". Irish Examiner. Irish Examiner. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Spotlight on NICB". DCU Website. Retrieved May 20, 2016.
- ^ "Spotlight on NICB". DCU Website. Retrieved May 20, 2016.
- ^ "CU Chemie Uetikon takes 80% share in Archport". DCU Website. Dublin City University. Retrieved Thursday 28 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Archport Ltd Company Profile". Bioportfolio. Bioportfolio. Retrieved 23 February 2017.
- ^ "CU Chemie Uetikon takes 80% share in Archport". DCU Website. Dublin City University. Retrieved Thursday 28 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Archport Ltd Company Profile". Bioportfolio. Bioportfolio. Retrieved 23 February 2017.
- ^ "CU Chemie Uetikon takes 80% share in Archport". DCU Website. Dublin City University. Retrieved Thursday 28 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Deal to expand DCU campus company". RTE Website. RTE. Retrieved Friday, 26 Jan 2007.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.breakingnews.ie. Breaking News.ie. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.irishexaminer.com. Irish Examiner. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "CU Chemie Uetikon takes 80% share in Archport". DCU Website. Dublin City University. Retrieved Thursday 28 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Deal to expand DCU campus company". RTE Website. RTE. Retrieved Friday, 26 Jan 2007.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.breakingnews.ie. Breaking News.ie. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.irishexaminer.com. Irish Examiner. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "CU Chemie Uetikon takes 80% share in Archport". DCU Website. Dublin City University. Retrieved Thursday 28 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Deal to expand DCU campus company". RTE Website. RTE. Retrieved Friday, 26 Jan 2007.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.breakingnews.ie. Breaking News.ie. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". www.irishexaminer.com. Irish Examiner. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Thirty jobs to be created in DCU pharmaceutical enterprise". http://www.irishexaminer.com. Irish Examiner. Retrieved Wednesday 27 September 2006.
{{cite web}}
: Check date values in:|accessdate=
(help); External link in
(help)|website=
- ^ "Chemical Firm Enters Biopharma CMO Sector". www.genengnews.com. Gene Engineering News. Retrieved September 15, 2008.
- ^ "Hillary wheels up to the DCU campus". www.irishtimes.com. The Irish Times. Retrieved Thursday, March 28, 2002.
{{cite web}}
: Check date values in:|accessdate=
(help)